NYSE - Delayed Quote USD

Emergent BioSolutions Inc. (EBS)

Compare
10.18 +0.83 (+8.88%)
At close: October 21 at 4:00 PM EDT
10.15 -0.03 (-0.29%)
Pre-Market: 4:03 AM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,074,400.00
1,023,000.00
1,076,100.00
1,639,400.00
1,462,200.00
Cost of Revenue
802,600.00
705,400.00
693,100.00
748,100.00
537,000.00
Gross Profit
271,800.00
317,600.00
383,000.00
891,300.00
925,200.00
Operating Expense
476,000.00
519,100.00
546,300.00
508,200.00
486,700.00
Operating Income
-204,200.00
-201,500.00
-163,300.00
383,100.00
438,500.00
Net Non Operating Interest Income Expense
-89,300.00
-87,900.00
-37,300.00
-34,500.00
-31,300.00
Other Income Expense
-284,600.00
-441,800.00
-18,400.00
-45,400.00
4,700.00
Pretax Income
-578,100.00
-731,200.00
-219,000.00
303,200.00
411,900.00
Tax Provision
8,900.00
29,300.00
-7,400.00
83,700.00
106,100.00
Net Income Common Stockholders
-587,000.00
-760,500.00
-211,600.00
219,500.00
305,800.00
Diluted NI Available to Com Stockholders
-587,000.00
-760,500.00
-211,600.00
219,500.00
305,800.00
Basic EPS
-11.22
-14.85
-4.47
4.32
5.79
Diluted EPS
-11.22
-14.85
-4.47
4.27
5.67
Basic Average Shares
52,150.00
51,200.00
50,100.00
53,500.00
52,700.00
Diluted Average Shares
52,150.00
51,200.00
50,100.00
54,100.00
53,800.00
Total Operating Income as Reported
-449,600.00
-726,400.00
-170,000.00
341,400.00
438,500.00
Total Expenses
1,278,600.00
1,224,500.00
1,239,400.00
1,256,300.00
1,023,700.00
Net Income from Continuing & Discontinued Operation
-587,000.00
-760,500.00
-211,600.00
219,500.00
305,800.00
Normalized Income
-360,981.00
-404,447.00
-205,101.00
249,524.00
305,800.00
Interest Expense
89,300.00
87,900.00
37,300.00
34,500.00
31,300.00
Net Interest Income
-89,300.00
-87,900.00
-37,300.00
-34,500.00
-31,300.00
EBIT
-488,800.00
-643,300.00
-181,700.00
337,700.00
443,200.00
EBITDA
-374,800.00
-518,200.00
-38,400.00
461,500.00
557,700.00
Reconciled Cost of Revenue
753,600.00
645,900.00
609,700.00
682,800.00
482,300.00
Reconciled Depreciation
114,000.00
125,100.00
143,300.00
123,800.00
114,500.00
Net Income from Continuing Operation Net Minority Interest
-587,000.00
-760,500.00
-211,600.00
219,500.00
305,800.00
Total Unusual Items Excluding Goodwill
-286,100.00
-450,700.00
-6,700.00
-41,700.00
--
Total Unusual Items
-286,100.00
-450,700.00
-6,700.00
-41,700.00
--
Normalized EBITDA
-88,700.00
-67,500.00
-31,700.00
503,200.00
557,700.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-60,081.00
-94,647.00
-201.00
-11,676.00
--
12/31/2020 - 11/15/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers